Blood Substitutes

Diaspirin Cross-Linked Hemoglobin is Vasoconstrictive

Published in Blood Weekly, November 2nd, 2000

Researchers in England have evaluated the impact that diaspirin cross-linked hemoglobin (DCLHb) might have on human arterial bypass conduits.

"Immediately available blood substitutes could transform medicine," wrote A.J. Ritchie and colleagues, Papworth Hospital, Cambridge. "In coronary artery surgery, vasoconstriction induced by some of these agents could have serious implications. We have examined some of the vasoactive effects of one of these blood substitute, DCLHb, on isolated rings of human arterial conduits."

Ritchie et al. published their study in the European Journal of Cardio-Thoracic Surgery ("The action of diaspirin cross-linked...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-11-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry